NFLX
59
-2
MSFT
60
5
MAC
71
4
XRAY
37
2
TDC
67
2
BXP
47
-3
FOX
33
-6
OI
47
2
COP
51
-2
MU
54
6
DFS
64
2
EL
52
4
WHR
36
-10
PEP
50
-13
PNR
72
10
DGX
46
-2
AMT
41
-4
PPL
52
-5
HST
49
-3
BLK
49
3
NFLX
59
-2
MSFT
60
5
MAC
71
4
XRAY
37
2
TDC
67
2
BXP
47
-3
FOX
33
-6
OI
47
2
COP
51
-2
MU
54
6
DFS
64
2
EL
52
4
WHR
36
-10
PEP
50
-13
PNR
72
10
DGX
46
-2
AMT
41
-4
PPL
52
-5
HST
49
-3
BLK
49
3
Financhill
Back

Adaptive Biotechnologies Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
34

ADPT
Adaptive Biotechnologies

Last Price:
2.75
Seasonality Move:
1.15%
Sell
14

NBY
NovaBay Pharmaceuticals

Last Price:
0.08
Seasonality Move:
-8.08%
Sell
34
Adaptive Biotechnologies (ADPT) is a Sell

Is Adaptive Biotechnologies a Buy, Sell or Hold?

  • The current Adaptive Biotechnologies [ADPT] share price is $2.60. The Score for ADPT is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • ADPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
14
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.08. The Score for NBY is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

ADPT Stock Price Chart

What is Adaptive Biotechnologies's stock price today?

  • The Adaptive Biotechnologies share price today is $2.60
    The current trend is relatively stagnant and ADPT is experiencing selling pressure, which indicates risk of future bearish movement.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.08
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing selling pressure, which indicates risk of future bearish movement.

ADPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.19 Sell
Relative Strength Index (14 RSI): 42.59 Sell
Chaikin Money Flow: -505204 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.52 - 3.02) Sell
Bollinger Bands (100): (3.04 - 4.6) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 31.87 Sell
Chaikin Money Flow: -1589019 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.08 - 0.12) Sell
Bollinger Bands (100): (0.1 - 0.22) Sell

ADPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.51 Buy
20-day SMA: 2.69 Sell
50-day SMA: 3.25 Sell
200-day SMA: 4.74 Sell
8-day EMA: 2.59 Buy
20-day EMA: 2.73 Sell
50-day EMA: 3.14 Sell
200-day EMA: 4.69 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.08 Sell
20-day SMA: 0.09 Sell
50-day SMA: 0.12 Sell
200-day SMA: 0.33 Sell
8-day EMA: 0.08 Sell
20-day EMA: 0.09 Sell
50-day EMA: 0.12 Sell
200-day EMA: 0.57 Sell

Adaptive Biotechnologies Earnings Growth & ADPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.02 per share, an increase this year of $0.11 per share, and an increase next year of $0.30 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.35 per share, an increase next quarter of $0.04 per share, an increase this year of $2.04 per share, and an increase next year of $0.30 per share.

Adaptive Biotechnologies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):